Virtus LifeSci Biotech Clinical Trials ETF Rating $44.92 +0.11 (+0.25%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.75Holdings in BBC have an aggregate rating of Moderate Buy based on 287 analyst ratings issued in the past year covering 25 companies (33.5% of the portfolio).BBC Aggregate Price Target$44.92High Prediction$44.92Average Prediction$44.92Low Prediction$44.92Holdings in BBC have an aggregate price target of $44.92 and a range of $44.92 to $44.92 covering 25 companies (33.5% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.19%ERASErasca$9.99-1.5%2.4519 of 5 stars2.50$17.88 78.9%10Upcoming Earnings1.81%ELVNEnliven Therapeutics$41.58-0.1%1.9481 of 5 stars2.67$43.40 4.4%6Analyst Downgrade1.71%TNGXTango Therapeutics$24.20+6.6%1.1771 of 5 stars2.77$22.44 -7.3%13News CoverageUpcoming EarningsInsider Trade1.67%ORKAOruka Therapeutics$68.95+3.7%3.2381 of 5 stars2.82$120.80 75.2%111.64%SYRESpyre Therapeutics$71.01+2.7%2.6995 of 5 stars3.00$85.08 19.8%13Earnings ReportGap Up1.59%ALMSAlumis$26.13+3.5%1.9802 of 5 stars2.92$38.60 47.7%12Positive NewsGap Down1.54%DNTHDianthus Therapeutics$90.24+1.0%3.3289 of 5 stars3.00$115.55 28.0%14News CoverageEarnings Report1.35%KODKodiak Sciences$42.66+0.9%0.9313 of 5 stars2.50$35.43 -17.0%81.35%RVMDRevolution Medicines$147.21-0.5%2.7926 of 5 stars3.10$78.94 -46.4%21Upcoming Earnings1.34%CRVSCorvus Pharmaceuticals$15.70-2.0%3.2464 of 5 stars2.75$33.33 112.3%8Upcoming Earnings1.31%RZLTRezolute$3.29-0.3%1.892 of 5 stars2.45$8.00 143.2%11News CoverageUpcoming Earnings1.29%DFTXDefinium Therapeutics$22.40+3.0%3.851 of 5 stars3.07$38.00 69.6%15Positive NewsUpcoming Earnings1.20%CGONCG Oncology$67.18-0.8%3.3852 of 5 stars2.77$79.55 18.4%13Upcoming Earnings1.20%INBXInhibrx Biosciences$128.12+0.1%1.7974 of 5 stars2.33$150.00 17.1%6Analyst Upgrade1.20%JBIOJade Biosciences$25.26+3.0%3.2647 of 5 stars2.89$31.17 23.4%91.19%RLAYRelay Therapeutics$13.00-0.7%3.2289 of 5 stars2.82$20.56 58.1%11News CoverageEarnings Report1.16%GHRSGH Research$21.28-1.9%2.2059 of 5 stars2.73$40.13 88.6%11Upcoming Earnings1.15%NKTRNektar Therapeutics$84.16-3.1%2.8775 of 5 stars2.73$140.63 67.1%11Trending NewsUpcoming Earnings1.13%TYRATyra Biosciences$33.93-3.4%2.3729 of 5 stars2.92$46.50 37.0%121.13%VIRVir Biotechnology$10.01-1.7%3.2596 of 5 stars2.89$20.38 103.5%9News CoverageUpcoming EarningsInsider Trade1.10%NTLAIntellia Therapeutics$13.31-4.0%2.8209 of 5 stars2.35$20.09 50.9%23Analyst RevisionGap Up1.10%CNTACentessa Pharmaceuticals$39.67-0.1%1.7723 of 5 stars2.21$40.70 2.6%141.08%ANABAnaptysBio$69.49-0.4%2.3829 of 5 stars2.75$76.18 9.6%12News CoverageAnalyst Forecast1.06%OMEROmeros$14.77-0.9%2.1547 of 5 stars2.83$40.33 173.1%61.05%TECXTectonic Therapeutic$29.36-1.0%3.0167 of 5 stars2.88$80.57 174.4%8Upcoming Earnings This page (NYSEARCA:BBC) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBC Stock Alerts